biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > The Chiesi thing...

<< Previous

Bullboard Posts

Next >>

Comment by InitiumMMXXIIIon Jan 04, 2025 2:03pm

34 Views

Post# 36387501

RE:The Chiesi thing...

And I understand that these Chiesi points don't match zwerp's opinion, an opinion that zwerp will never back up because he just hasn't studied anything about all of this.

He doesn't have enough knowledge to discuss Bioasis. He's only interested in putting me in my place. So he will hold on to any narrative that he thinks will damage me.

Sounds like DJ, Donald J. Youknowwho.

Well, I'm not DJ. I'm JD.

I'm interested in what happened. It's mostly in those 460 pages, the proposal. Go read that proposal, zwerp, and figure it out for yourself. No blah, blah, blah, zwerp. It's all in the documentation, zwerp. I don't have to make anything up like you do.

jd

<< Previous

Bullboard Posts

Next >>

Abcourt Mines launches Flordin property drill campaign